FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

2863211000001100: Destolit 150mg tablets (Norgine Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17268901000001114 Destolit 150mg tablets (Norgine Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
38108501000001112 Destolit 150mg tablets (Norgine Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Destolit 150mg tablets (Norgine Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Destolit 150mg tablets (Norgine Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Destolit 150mg tablets (Norgine Ltd) Is a Product containing precisely ursodeoxycholic acid 150 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Destolit 150mg tablets (Norgine Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Destolit 150mg tablets (Norgine Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Destolit 150mg tablets (Norgine Ltd) Has active ingredient Ursodeoxycholic acid false Inferred relationship Existential restriction modifier
Destolit 150mg tablets (Norgine Ltd) Has active ingredient Ursodiol false Inferred relationship Existential restriction modifier
Destolit 150mg tablets (Norgine Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Destolit 150mg tablets (Norgine Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Destolit 150mg tablets (Norgine Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Destolit 150mg tablets (Norgine Ltd) Is a Destolit true Inferred relationship Existential restriction modifier
Destolit 150mg tablets (Norgine Ltd) Has specific active ingredient Ursodeoxycholic acid true Inferred relationship Existential restriction modifier
Destolit 150mg tablets (Norgine Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Destolit 150mg tablets (Norgine Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Destolit 150mg tablets (Norgine Ltd) 60 tablet 6 x 10 tablets Is pack of False Destolit 150mg tablets (Norgine Ltd) Inferred relationship Existential restriction modifier
Destolit 150mg tablets (Norgine Ltd) 60 tablet 6 x 10 tablets Has AMP True Destolit 150mg tablets (Norgine Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start